EDMUND TORKELSON: Open Payments
NPI 1083701833 · BEAVERTON, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,541 in 78 payments from 24 companies in 2025. Trend: 2023 $1,405 · 2024 $1,503 · 2025 $1,541
Food & beverage: $1,541
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $212 |
| ABBVIE INC. | 15 | $210 |
| ViiV Healthcare Company | 9 | $175 |
| Novartis Pharmaceuticals Corporation | 6 | $133 |
| AstraZeneca Pharmaceuticals LP | 8 | $131 |
| Lilly USA, LLC | 4 | $96 |
| PFIZER INC. | 4 | $94 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Gilead Sciences, Inc. | 2 | $47 |
| Merck Sharp & Dohme LLC | 2 | $47 |
Products named: EVENITY, LEQVIO, QULIPTA, MOUNJARO, APRETUDE, BREZTRI, UBRELVY, DOVATO.
Industry payments across OR — which companies pay providers there.
